Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma
Author:
Affiliation:
1. Center for Integrated Oncology (CIO); Med. Klinik and Poliklinik III, University Hospital Bonn; Bonn Germany
2. Bonn-Rhein-Sieg University of Applied Sciences; Rheinbach Germany
Publisher
Wiley
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2326/fullpdf
Reference23 articles.
1. Epidemiology of multiple myeloma;Becker;Recent Results Cancer Res,2011
2. Clinical trials on CIK cells: first report of the International Registry on CIK Cells (IRCC);Hontscha;J Cancer Res Clin Oncol,2011
3. Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety;Ma;Exp Hematol Oncol,2012
4. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the International Registry on CIK Cells (IRCC);Schmeel;J Cancer Res Clin Oncol,2015
5. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity;Schmidt-Wolf;J Exp Med,1991
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review);Oncology Reports;2024-08-14
2. Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands;International Journal of Molecular Sciences;2024-04-26
3. Human leukocyte antigen and tumor immunotherapy (Review);International Journal of Oncology;2023-04-26
4. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy;Pharmacology & Therapeutics;2022-07
5. A method of delivering an anti-p21Ras single-chain antibody fragment to tumor sites in vivo;Journal of Drug Delivery Science and Technology;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3